关注
Somya Ranjan Dash
Somya Ranjan Dash
在 kiitbiotech.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis
C Sethy, K Goutam, B Das, SR Dash, CN Kundu
Vascular Pharmacology 140, 106865, 2021
292021
Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway
R Pradhan, S Paul, B Das, S Sinha, SR Dash, M Mandal, CN Kundu
The Journal of Nutritional Biochemistry 113, 109257, 2023
212023
Promising opportunities and potential risk of nanoparticle on the society
SR Dash, CN Kundu
IET nanobiotechnology 14 (4), 253-260, 2020
182020
Quinacrine based gold hybrid nanoparticles caused apoptosis through modulating replication fork in oral cancer stem cells
KC Hembram, SR Dash, B Das, C Sethy, S Chatterjee, BK Bindhani, ...
Molecular pharmaceutics 17 (7), 2463-2472, 2020
152020
Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells
B Das, SR Dash, H Patel, S Sinha, S Bhal, S Paul, C Das, R Pradhan, ...
Phytomedicine 117, 154914, 2023
142023
Advances in nanomedicine for the treatment of infectious diseases caused by viruses
SR Dash, CN Kundu
Biomaterials Science 11 (10), 3431-3449, 2023
142023
Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping
S Chatterjee, AK Dhal, S Paul, S Sinha, B Das, SR Dash, CN Kundu
Journal of Cancer Research and Clinical Oncology 148 (12), 3521-3535, 2022
142022
Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway
S Sinha, S Chatterjee, S Paul, B Das, SR Dash, C Das, CN Kundu
Experimental Cell Research 420 (1), 113338, 2022
142022
NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells
SR Dash, S Chatterjee, S Sinha, B Das, S Paul, R Pradhan, C Sethy, ...
Nanomedicine: Nanotechnology, Biology and Medicine 40, 102502, 2022
142022
Fine needle aspiration as a primary diagnostic procedure of breast lumps.
AK Patra, RN Mallik, S Dash
Indian Journal of Pathology & Microbiology 34 (4), 259-264, 1991
121991
Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β
SR Dash, B Das, C Das, S Sinha, S Paul, R Pradhan, CN Kundu
Nanomedicine 18 (1), 19-33, 2023
92023
Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells
S Paul, S Chatterjee, S Sinha, SR Dash, R Pradhan, B Das, K Goutam, ...
Expert Opinion on Therapeutic Targets 27 (10), 999-1015, 2023
72023
Photothermal therapy: a new approach to eradicate cancer
SR Dash, CN Kundu
Current Nanoscience 18 (1), 31-47, 2022
62022
Surface functionalized gold nanorods for plasmonic photothermal therapy
R Panda, SR Dash, SS Satapathy, CN Kundu, J Tripathy
Materials Today: Proceedings 47, 1193-1196, 2021
52021
Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells
B Das, C Sethy, S Chatterjee, SR Dash, S Sinha, S Paul, K Goutam, ...
Journal of Cell Communication and Signaling 17 (4), 1371-1388, 2023
42023
Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300
C Das, SR Dash, S Sinha, S Paul, B Das, S Bhal, C Sethy, CN Kundu
Medical Oncology 40 (12), 351, 2023
42023
Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through …
R Pradhan, S Paul, SS Acharya, S Sinha, SR Dash, CN Kundu
The Journal of Nutritional Biochemistry 125, 109568, 2024
32024
The role of viruses in cancer progression versus cancer treatment: A dual paradigm
SR Dash, A Kundu, CN Kundu
Life Sciences, 122506, 2024
22024
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60 …
S Sinha, S Paul, SS Acharya, C Das, SR Dash, S Bhal, R Pradhan, B Das, ...
Medical Oncology 41 (2), 49, 2024
22024
Cancer-induced pain management by nanotechnology-based approach
SR Dash, CN Kundu
Current Pharmaceutical Biotechnology 24 (11), 1365-1375, 2023
22023
系统目前无法执行此操作,请稍后再试。
文章 1–20